See more : Elis SA (ELIS.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Bangkok Dusit Medical Services Public Company Limited (BDMS.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bangkok Dusit Medical Services Public Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Çelebi Hava Servisi A.S. (CLEBI.IS) Income Statement Analysis – Financial Results
- Astral Limited (ASTRAL.NS) Income Statement Analysis – Financial Results
- Delorean Corporation Limited (DEL.AX) Income Statement Analysis – Financial Results
- Suzuken Co., Ltd. (SZUKF) Income Statement Analysis – Financial Results
- Arabian Mills for Food Products (2285.SR) Income Statement Analysis – Financial Results
Bangkok Dusit Medical Services Public Company Limited (BDMS.BK)
About Bangkok Dusit Medical Services Public Company Limited
Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals. The company owns and manages 6 hospital groups, including Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. It operates holistic clinical wellness. In addition, the company operates hotels and restaurant; sells health and cosmetic products; provides accounting, health insurance, laboratory services, investment, information technology, training, skin and aesthetics telemedicine, genome sequencing, insurance brokerage, air medical transportation, facility management, and property management services, as well as asset management services; and manufactures and distributes medicine and pharmaceutical products. Further, it is involved in the e-commerce and real estate business. The company operates 47 hospitals in Thailand and Cambodia. Bangkok Dusit Medical Services Public Company Limited was incorporated in 1969 and is based in Bangkok, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 100.85B | 91.93B | 74.45B | 68.07B | 82.72B | 78.42B | 71.93B | 67.99B | 62.86B | 56.05B | 50.62B | 45.48B | 36.23B | 23.73B | 21.75B | 21.35B | 18.52B | 15.79B | 10.72B | 5.64B | 3.31B |
| Cost of Revenue | 63.41B | 58.33B | 49.46B | 46.37B | 54.28B | 51.55B | 47.98B | 45.28B | 41.13B | 36.47B | 32.98B | 29.24B | 23.68B | 13.66B | 12.45B | 11.88B | 10.24B | 8.67B | 5.93B | 0.00 | 0.00 |
| Gross Profit | 37.44B | 33.60B | 24.99B | 21.70B | 28.45B | 26.87B | 23.96B | 22.71B | 21.73B | 19.58B | 17.64B | 16.24B | 12.56B | 10.07B | 9.30B | 9.47B | 8.28B | 7.12B | 4.79B | 5.64B | 3.31B |
| Gross Profit Ratio | 37.12% | 36.55% | 33.56% | 31.88% | 34.39% | 34.27% | 33.31% | 33.40% | 34.57% | 34.93% | 34.85% | 35.71% | 34.66% | 42.44% | 42.75% | 44.36% | 44.73% | 45.08% | 44.66% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 19.81B | 17.65B | 15.03B | 14.16B | 17.45B | 16.00B | 14.49B | 13.64B | 12.83B | 11.26B | 10.55B | 8.97B | 7.22B | 4.80B | 4.47B | 4.73B | 4.20B | 4.99B | 3.42B | 1.52B | 826.15M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 19.81B | 17.65B | 15.03B | 14.16B | 17.45B | 16.00B | 14.49B | 13.64B | 12.83B | 11.26B | 10.55B | 8.97B | 7.22B | 4.80B | 4.47B | 4.73B | 4.20B | 4.99B | 3.42B | 1.52B | 826.15M |
| Other Expenses | -1.30B | -1.03B | -1.26B | -983.06M | -1.05B | 915.31M | 839.56M | 858.86M | 798.44M | 629.24M | 543.02M | 515.77M | -970.83M | 1.89B | 2.09B | 1.91B | 1.63B | -126.85M | 24.00M | 3.25B | 1.91B |
| Operating Expenses | 18.50B | 16.62B | 13.77B | 13.18B | 16.40B | 15.08B | 13.65B | 12.79B | 12.03B | 10.63B | 10.01B | 8.45B | 6.25B | 6.69B | 6.56B | 6.64B | 5.83B | 4.87B | 3.45B | 4.77B | 2.73B |
| Cost & Expenses | 81.92B | 74.95B | 63.23B | 59.55B | 70.67B | 66.63B | 61.62B | 58.06B | 53.16B | 47.10B | 42.98B | 37.69B | 29.93B | 20.35B | 19.01B | 18.52B | 16.07B | 13.54B | 9.38B | 4.77B | 2.73B |
| Interest Income | 173.47M | 79.82M | 73.14M | 39.10M | 110.08M | 58.05M | 51.76M | 52.22M | 47.30M | 77.20M | 62.66M | 56.50M | 63.05M | 54.17M | 33.53M | 41.06M | 13.22M | 27.45M | 4.60M | 0.00 | 0.00 |
| Interest Expense | 546.59M | 632.07M | 728.46M | 870.93M | 928.76M | 1.17B | 1.54B | 881.01M | 1.14B | 972.23M | 957.03M | 849.41M | 770.45M | 584.35M | 641.34M | 646.84M | 688.09M | 545.75M | 275.63M | 121.66M | 101.07M |
| Depreciation & Amortization | 5.85B | 5.95B | 6.32B | 6.41B | 5.71B | 5.35B | 5.17B | 4.80B | 4.39B | 3.70B | 3.24B | 2.95B | 2.67B | 2.12B | 2.29B | 2.17B | 2.18B | 1.60B | 1.04B | 404.70M | 215.88M |
| EBITDA | 24.96B | 23.02B | 17.62B | 17.41B | 25.49B | 17.21B | 18.42B | 15.01B | 14.22B | 12.68B | 10.88B | 13.57B | 8.87B | 5.51B | 5.26B | 5.00B | 4.54B | 3.92B | 2.39B | 1.35B | 794.12M |
| EBITDA Ratio | 24.75% | 25.08% | 23.69% | 22.40% | 22.89% | 24.13% | 23.56% | 23.75% | 24.49% | 24.62% | 23.57% | 25.86% | 24.48% | 24.82% | 23.09% | 23.42% | 25.12% | 24.81% | 21.97% | 24.16% | 23.96% |
| Operating Income | 18.94B | 16.99B | 11.23B | 10.96B | 13.18B | 11.79B | 10.31B | 9.92B | 9.70B | 8.95B | 7.63B | 7.79B | 6.31B | 3.16B | 2.33B | 2.41B | 1.82B | 1.77B | 1.34B | 861.89M | 582.27M |
| Operating Income Ratio | 18.78% | 18.48% | 15.08% | 16.10% | 15.94% | 15.03% | 14.33% | 14.60% | 15.43% | 15.97% | 15.08% | 17.12% | 17.40% | 13.31% | 10.72% | 11.27% | 9.82% | 11.21% | 12.52% | 15.29% | 17.57% |
| Total Other Income/Expenses | -283.72M | -510.42M | -634.21M | -558.88M | 203.77M | 598.57M | 2.83B | 771.21M | 397.06M | 389.28M | 279.13M | 1.99B | -222.23M | -299.75M | 0.00 | 0.00 | 0.00 | 0.00 | -275.63M | -26.76M | -105.10M |
| Income Before Tax | 18.65B | 16.48B | 10.59B | 10.40B | 19.88B | 12.39B | 13.14B | 10.69B | 10.10B | 9.34B | 7.91B | 9.77B | 6.08B | 3.16B | 2.33B | 2.41B | 1.82B | 1.77B | 1.04B | 835.13M | 477.17M |
| Income Before Tax Ratio | 18.49% | 17.93% | 14.23% | 15.28% | 24.04% | 15.80% | 18.26% | 15.73% | 16.06% | 16.66% | 15.63% | 21.49% | 16.79% | 13.31% | 10.72% | 11.27% | 9.82% | 11.21% | 9.70% | 14.82% | 14.40% |
| Income Tax Expense | 3.75B | 3.23B | 2.10B | 2.75B | 3.87B | 2.74B | 2.56B | 1.92B | 1.86B | 1.67B | 1.39B | 1.52B | 1.46B | 779.39M | 546.89M | 688.51M | 527.30M | 385.95M | 207.99M | 211.97M | 107.46M |
| Net Income | 14.38B | 12.61B | 7.94B | 7.21B | 15.52B | 9.19B | 10.22B | 8.39B | 7.92B | 7.39B | 6.26B | 7.94B | 4.39B | 2.30B | 1.73B | 1.66B | 1.24B | 1.32B | 832.11M | 623.15M | 384.47M |
| Net Income Ratio | 14.25% | 13.71% | 10.66% | 10.60% | 18.76% | 11.72% | 14.20% | 12.34% | 12.60% | 13.19% | 12.37% | 17.45% | 12.10% | 9.67% | 7.93% | 7.79% | 6.72% | 8.38% | 7.76% | 11.06% | 11.60% |
| EPS | 0.90 | 0.79 | 0.50 | 0.45 | 0.99 | 0.59 | 0.66 | 0.54 | 0.52 | 0.48 | 0.40 | 0.51 | 0.30 | 0.19 | 0.14 | 0.14 | 0.10 | 0.11 | 0.07 | 0.07 | 0.05 |
| EPS Diluted | 0.90 | 0.79 | 0.50 | 0.45 | 0.99 | 0.59 | 0.66 | 0.54 | 0.52 | 0.48 | 0.40 | 0.51 | 0.30 | 0.19 | 0.14 | 0.14 | 0.10 | 0.11 | 0.07 | 0.07 | 0.05 |
| Weighted Avg Shares Out | 15.89B | 15.89B | 15.89B | 15.89B | 15.74B | 15.57B | 15.49B | 15.49B | 15.49B | 15.49B | 15.46B | 15.45B | 14.62B | 12.19B | 12.14B | 12.14B | 11.96B | 11.77B | 11.63B | 8.75B | 7.50B |
| Weighted Avg Shares Out (Dil) | 15.89B | 15.89B | 15.89B | 15.89B | 15.74B | 15.57B | 15.49B | 15.49B | 15.49B | 15.49B | 15.46B | 15.45B | 14.62B | 12.19B | 12.14B | 12.14B | 11.96B | 11.77B | 11.63B | 8.75B | 7.50B |
Source: https://incomestatements.info
Category: Stock Reports